Detalhe da pesquisa
1.
Anti-Tumor Immunogenicity of the Oncolytic Virus CF33-hNIS-antiPDL1 against Ex Vivo Peritoneal Cells from Gastric Cancer Patients.
Int J Mol Sci
; 24(18)2023 Sep 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-37762490
2.
Pre-conditioning modifies the TME to enhance solid tumor CAR T cell efficacy and endogenous protective immunity.
Mol Ther
; 29(7): 2335-2349, 2021 07 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33647456
3.
Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models.
Int J Mol Sci
; 21(19)2020 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33023064
4.
Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose.
J Transl Med
; 16(1): 110, 2018 04 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-29699566
5.
Using Oncolytic Virus to Retask CD19-Chimeric Antigen Receptor T Cells for Treatment of Pancreatic Cancer: Toward a Universal Chimeric Antigen Receptor T-Cell Strategy for Solid Tumor.
J Am Coll Surg
; 238(4): 436-447, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38214445
6.
Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases.
J Immunother Cancer
; 11(4)2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-37019471
7.
Chimeric Antigen Receptor-T Cell and Oncolytic Viral Therapies for Gastric Cancer and Peritoneal Carcinomatosis of Gastric Origin: Path to Improving Combination Strategies.
Cancers (Basel)
; 15(23)2023 Nov 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38067366
8.
Peritoneal-directed chimeric oncolytic virus CF17 prevents malignant ascites and improves survival in gastric cancer peritoneal metastases.
Mol Ther Oncolytics
; 31: 100734, 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37915757
9.
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting.
bioRxiv
; 2023 Jan 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36711615
10.
Antigen-dependent IL-12 signaling in CAR T cells promotes regional to systemic disease targeting.
Nat Commun
; 14(1): 4737, 2023 08 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37550294
11.
PET imaging and treatment of pancreatic cancer peritoneal carcinomatosis after subcutaneous intratumoral administration of a novel oncolytic virus, CF33-hNIS-antiPDL1.
Mol Ther Oncolytics
; 24: 331-339, 2022 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35118191
12.
Priming stroma with a vitamin D analog to optimize viroimmunotherapy for pancreatic cancer.
Mol Ther Oncolytics
; 24: 864-872, 2022 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-35317522
13.
CF33-hNIS-antiPDL1 virus primes pancreatic ductal adenocarcinoma for enhanced anti-PD-L1 therapy.
Cancer Gene Ther
; 29(6): 722-733, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108669
14.
Toward comprehensive imaging of oncolytic viroimmunotherapy.
Mol Ther Oncolytics
; 23: 303-310, 2021 Dec 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34786474
15.
Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity.
Mol Cancer Ther
; 20(1): 173-182, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33262221
16.
Oncolytic poxvirus CF33-hNIS-ΔF14.5 favorably modulates tumor immune microenvironment and works synergistically with anti-PD-L1 antibody in a triple-negative breast cancer model.
Oncoimmunology
; 9(1): 1729300, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32158622
17.
Novel Chimeric Immuno-Oncolytic Virus CF33-hNIS-antiPDL1 for the Treatment of Pancreatic Cancer.
J Am Coll Surg
; 230(4): 709-717, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32032721
18.
Effective combination immunotherapy using oncolytic viruses to deliver CAR targets to solid tumors.
Sci Transl Med
; 12(559)2020 09 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32878978
19.
A Novel Oncolytic Chimeric Orthopoxvirus Encoding Luciferase Enables Real-Time View of Colorectal Cancer Cell Infection.
Mol Ther Oncolytics
; 9: 13-21, 2018 Jun 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29988502
20.
Regional Delivery of Chimeric Antigen Receptor-Engineered T Cells Effectively Targets HER2+ Breast Cancer Metastasis to the Brain.
Clin Cancer Res
; 24(1): 95-105, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29061641